Cargando…
Plasma levels of apelin are reduced in patients with liver fibrosis and cirrhosis but are not correlated with circulating levels of bone morphogenetic protein 9 and 10
BACKGROUND: The peptide apelin is expressed in human healthy livers and is implicated in the development of hepatic fibrosis and cirrhosis. Mutations in the bone morphogenetic protein receptor type II (BMPR-II) result in reduced plasma levels of apelin in patients with heritable pulmonary arterial h...
Autores principales: | Owen, Nicola E., Nyimanu, Duuamene, Kuc, Rhoda E., Upton, Paul D., Morrell, Nicholas W., Alexander, Graeme J., Maguire, Janet J., Davenport, Anthony P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883214/ https://www.ncbi.nlm.nih.gov/pubmed/33171278 http://dx.doi.org/10.1016/j.peptides.2020.170440 |
Ejemplares similares
-
Apelin-36-[L28A] and Apelin-36-[L28C(30kDa-PEG)] peptides that improve diet induced obesity are G protein biased ligands at the apelin receptor
por: Nyimanu, Duuamene, et al.
Publicado: (2019) -
The therapeutic potential of apelin in kidney disease
por: Chapman, Fiona A., et al.
Publicado: (2021) -
Apelin is expressed throughout the human kidney, is elevated in chronic kidney disease & associates independently with decline in kidney function
por: Nyimanu, Duuamene, et al.
Publicado: (2022) -
A novel cyclic biased agonist of the apelin receptor, MM07, is disease modifying in the rat monocrotaline model of pulmonary arterial hypertension
por: Yang, Peiran, et al.
Publicado: (2019) -
Development and validation of an LC-MS/MS method for detection and quantification of in vivo derived metabolites of [Pyr(1)]apelin-13 in humans
por: Nyimanu, Duuamene, et al.
Publicado: (2019)